UBS Group’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
|
|||||
|
2025
Q1 | $912K | Sell |
|
|||||
|
2024
Q4 | $1.5M | Buy |
|
|||||
|
2024
Q3 | $452K | Buy |
|
|||||
|
2024
Q2 | $70.3K | Buy |
|
|||||
|
2024
Q1 | $8.52K | Sell |
|
|||||
|
2023
Q4 | $4.63K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.27K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $11K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $8K | Sell |
|
|||||
|
2021
Q3 | $44K | Sell |
|
|||||
|
2021
Q2 | $56K | Sell |
|
|||||
|
2021
Q1 | $74K | Sell |
|
|||||
|
2020
Q4 | $128K | Buy |
|
|||||
|
2020
Q3 | $68K | Sell |
|
|||||
|
2020
Q2 | $185K | Buy |
|
|||||
|
2020
Q1 | $42K | Buy |
|
|||||
|
2019
Q4 | $58K | Hold |
|
|||||
|
2019
Q3 | $32K | Hold |
|
|||||
|
2019
Q2 | $42K | Sell |
|
|||||
|
2019
Q1 | $92K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $23K | Buy |
|